Legal Opinion
Painters & Allied Trades Dist. Council 82 Health Care Fund v. Forest Labs., Inc. (In re Celexa & Lexapro Mktg. & Sales Practices Litig.)
District Court, District of Columbia
Decided January 26, 2018No. MDL No. 09–02067–NMG; Civil Action No. 13–13113–NMG; Civil Action No. 14–13848–NMGPublishedCited by 2 opinions
1Opinion of the Court
GORTON, United States District Judge
These cases arise out of the marketing and sales of the anti-depressant drugs Celexa and Lexapro by defendants Forest Laboratories, Inc., Forest Laboratories, LLC and Forest Pharmaceuticals, Inc. (collectively, "defendants" or "Forest"). Plaintiffs Delana Kiossovski and Renee Ramirez (collectively, "the Kiossovski plaintiffs") and plaintiff Painters and Allied Trades District Council 82 Health Care Fund ("Painters") (collectively "plaintiffs") allege that defendants 1) engaged in a fraudulent marketing scheme designed to induce consumers to purchase Celexa…
2Cases cited25 opinions
- Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
- Celotex Corp. v. Catrett, Administratrix of the Estate of CatrettSupreme Court of the United States · 1986
- Sedima, S. P. R. L. v. Imrex Co.Supreme Court of the United States · 1985
- Samuel Mesnick v. General Electric CompanyCourt of Appeals for the First Circuit · 1991
- Holmes v. Securities Investor Protection CorporationSupreme Court of the United States · 1992
20 more not listed; retrieve them via the Exa API.
3Cited by2 opinions
- Painters & Allied Trades Dist. Council 82 Health Care Fund v. Forest Pharm., Inc. (In Re Celexa & Lexapro Mktg. & Sales Practices Litig.)Court of Appeals for the First Circuit · 2019
- Painters and Allied Trades v. Forest Pharmaceuticals, Inc.Court of Appeals for the First Circuit · 2019